ImmuCell Corporation Operating Lease, Liability, Current
ImmuCell Corporation (ICCC) had Operating Lease, Liability, Current of $121.86 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Current $121.86K.
- 2026-03-31: Operating Lease, Liability, Current $88.59K.
- 2025-12-31: Operating Lease, Liability, Current $85.49K.
- 2025-09-30: Operating Lease, Liability, Current $82.44K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $121.86K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $88.59K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $85.49K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $82.44K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $322.75K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $380.96K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $432.07K 10-K · filed 2026-03-30 |
| 2024-09-30 | $482.24K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $533.32K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $597.29K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $644.28K 10-K · filed 2025-03-28 |
| 2023-09-30 | $67.82K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $52.22K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $33.96K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $31.76K 10-K · filed 2024-04-01 |
| 2022-09-30 | $22.92K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $112.09K 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $110.05K 10-Q/A · filed 2022-11-21 |
| 2021-12-31 | $108.01K 10-K · filed 2023-03-29 |
| 2021-09-30 | $106.14K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $104.26K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $102.39K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $100.51K 10-K · filed 2022-03-30 |
| 2020-09-30 | $97.46K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $94.40K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $93.25K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |